Stanger Frédéric V, Harms Alexander, Dehio Christoph, Schirmer Tilman
Focal Area Structural Biology and Biophysics, Biozentrum, University of Basel, Basel, Switzerland.
Focal Area Infection Biology, Biozentrum, University of Basel, Basel, Switzerland.
PLoS One. 2016 Sep 22;11(9):e0163654. doi: 10.1371/journal.pone.0163654. eCollection 2016.
FIC domain proteins mediate post-translational modifications of target proteins, which typically results in their inactivation. Depending on the conservation of crucial active site residues, the FIC fold serves as structural scaffold for various enzymatic activities, mostly target adenylylation. The founding member of the vast Fic protein family, EcFicT, was identified in Escherichia coli some time ago. The G55R point mutant of EcFicT displays the "filamentation induced by cAMP" (Fic) phenotype at high 3',5'-cyclic adenosine monophosphate (cAMP) concentrations and elevated temperature, but the underlying molecular mechanism and any putative biochemical activity of EcFicT have remained unknown. EcFicT belongs to class I Fic toxin proteins that are encoded together with a small inhibitory protein (antitoxin), named EcFicA in E. coli. Here, we report the crystal structures of two mutant EcFicT/EcFicA complexes (EcFicTG55RA and EcFicTAE28G) both showing close resemblance with the structure of the AMP-transferase VbhT from Bartonella schoenbuchensis in complex with its cognate antitoxin VbhA. However, crucial differences in the active site of EcFicT compared to VbhT and other AMP-transferases rationalize the lack of evidence for adenylylation activity. Comprehensive bioinformatic analysis suggests that EcFicT has evolved from canonical AMP-transferases and has acquired a conserved binding site for a yet to be discovered novel substrate. The G55R mutation has no effect on structure or thermal stability of EcFicT, such that the molecular basis for its associated Fic phenotype remains elusive. We anticipate that this structure will inspire further bioinformatic and experimental analyses in order to characterize the enzymatic activity of EcFicT and help revealing its physiological role.
FIC结构域蛋白介导靶蛋白的翻译后修饰,这通常会导致其失活。根据关键活性位点残基的保守性,FIC折叠为各种酶活性提供结构支架,主要是靶标腺苷酸化。广泛的Fic蛋白家族的创始成员EcFicT,早在一段时间前就在大肠杆菌中被鉴定出来。EcFicT的G55R点突变体在高浓度3',5'-环磷酸腺苷(cAMP)和升高的温度下表现出“cAMP诱导的丝状化”(Fic)表型,但其潜在的分子机制以及EcFicT的任何假定生化活性仍然未知。EcFicT属于I类Fic毒素蛋白,它与一种小的抑制性蛋白(抗毒素)一起编码,在大肠杆菌中称为EcFicA。在这里,我们报告了两种突变的EcFicT/EcFicA复合物(EcFicTG55RA和EcFicTAE28G)的晶体结构,两者都与来自Bartonella schoenbuchensis的AMP转移酶VbhT与其同源抗毒素VbhA形成复合物的结构非常相似。然而,与VbhT和其他AMP转移酶相比,EcFicT活性位点的关键差异解释了缺乏腺苷酸化活性的证据。全面的生物信息学分析表明,EcFicT是从典型的AMP转移酶进化而来的,并获得了一个尚未发现的新型底物的保守结合位点。G55R突变对EcFicT的结构或热稳定性没有影响,因此其相关Fic表型的分子基础仍然难以捉摸。我们预计,这种结构将激发进一步的生物信息学和实验分析,以表征EcFicT的酶活性,并有助于揭示其生理作用。